Efficacy of a Lactococcus lactis DeltapyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes. (65/121)

 (+info)

Biocontainment strategies for live lactic acid bacteria vaccine vectors. (66/121)

 (+info)

Acid-fast staining and Petroff-Hausser chamber counting of mycobacterial cells in liquid suspension. (67/121)

 (+info)

A secure semi-field system for the study of Aedes aegypti. (68/121)

 (+info)

Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects. (69/121)

 (+info)

Armored geomembrane cover engineering. (70/121)

 (+info)

Biosafety considerations in industries with production methods based on the use of recombinant deoxyribonucleic acid. (71/121)

Since no occupational accidents or diseases have been attributed specifically to the use of constructions containing recombinant deoxyribonucleic acid (rDNA), this paper evaluates the occupational health risks in industries utilizing genetically manipulated organisms mainly on the basis of theoretical considerations. Bacteria, filamentous fungi, yeasts, and mammalian cells in culture are in use. For each of these systems the possible hazards are considered. Concerning microbial production systems, infections are regarded as the main problem, but the risk of infection is considered extremely low. As for cells in culture, only dormant viruses are regarded as problematic, but well-defined production cell lines should not contain such undetected and dangerous viruses. Overall, the additional risks posed by rDNA-modified micro-organisms are minor. Only long-term observations can, however, confirm this assumption, and consequently the highest feasible containment measures should still be used in the years to come.  (+info)

Intrabronchial inoculation of cynomolgus macaques with cowpox virus. (72/121)

 (+info)